2.18
+0.08(+3.81%)
Currency In USD
| Previous Close | 2.1 |
| Open | 2.08 |
| Day High | 2.18 |
| Day Low | 2 |
| 52-Week High | 3.78 |
| 52-Week Low | 1.33 |
| Volume | 3,962 |
| Average Volume | 27,681 |
| Market Cap | 15.73M |
| PE | -1.79 |
| EPS | -1.22 |
| Moving Average 50 Days | 2.09 |
| Moving Average 200 Days | 2.65 |
| Change | 0.08 |
NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025
GlobeNewswire Inc.
May 05, 2025 1:00 PM GMT
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern TimeCARMEL, Ind., May 05, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology c
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
GlobeNewswire Inc.
Apr 15, 2025 1:00 PM GMT
CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children
NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025
GlobeNewswire Inc.
Mar 12, 2025 1:00 PM GMT
CARMEL, Ind., March 12, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children